Dijkhorst, Phillip J. http://orcid.org/0000-0003-2913-8559
Monpellier, Valerie M.
Terwee, Caroline B.
Liem, Ronald S. L.
van Wagensveld, Bart A.
Janssen, Ignace M. C.
Ottosson, Johan
Halpern, Bruno
Flint, Stuart W.
van Rossum, Elisabeth F. C.
Saadi, Alend
West-Smith, Lisa
O’Kane, Mary
Halford, Jason C. G.
Coulman, Karen D.
Al-Sabah, Salman
Dixon, John B.
Brown, Wendy A.
Ramos Salas, Ximena
Abbott, Sally
Budin, Alyssa J.
Holland, Jennifer F.
Poulsen, Lotte
Welbourn, Richard
Wijling, Natasja
Divine, Laura
Isack, Nadya
Birney, Susie
Keenan, J. M. Bernadette
Kyle, Theodore K.
Bahlke, Melanie
Healing, Andrew
Patton, Ian
de Vries, Claire E. E.
Funding for this research was provided by:
Medtronic
Novo Nordisk
Johnson and Johnson
Goodlife
Fitforme
Article History
Received: 29 December 2023
Revised: 21 June 2024
Accepted: 1 July 2024
First Online: 15 July 2024
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
: Claire E. E. de Vries and Valerie M. Monpellier founded the S.Q.O.T. initiative. The initiative was cofounded by Bart A. van Wagensveld, Ignace M. C. Janssen, and Ronald S. L. Liem. Phillip J Dijkhorst joined the board of the S.Q.O.T. initiative in 2021. Claire E. E. de Vries, Ronald S. L. Liem, and Lotte Poulsen were involved in developing the eating scales in the BODY-Q. Claire E.E. de Vries and Ronald S. L. Liem are members of the organizing committee and were not permitted to participate in, nor influence, discussions during the S.Q.O.T. consensus meetings or the voting rounds. Lotte Poulsen was not permitted to participate in the voting rounds if the BODY-Q was available for a specific patient-reported outcome domain. None of the aforementioned persons received financial compensation for developing the BODY-Q or for any other BODY-Q-related activity. Ignace M. C. Janssen was a consultant at Johnson & Johnson and the Dutch Obesity Clinic. Johan Ottosson previously sat on the advisory board of Novo Nordisk. The University of Leeds received payments for Professor Halford’s work on ACTION-Teens. Over the last 3 years, Stuart W. Flint reported research grants from the National Institute for Health Research, the Office of Health Improvement & Disparities, Public Health England, Doncaster Council, West Yorkshire Combined Authority, Johnson & Johnson, Novo Nordisk, and the University of Leeds. He reported receiving personal fees from the Royal College of General Practitioners and institutional fees from Public Health England, and he received funding to attend meetings at the parliament of the UK, Novo Nordisk, Johnson & Johnson, and Safefood. Stuart W. Flint also reported unpaid roles with Obesity UK. Bruno Halpern sat on the advisory boards of Novo Nordisk, Lilly, and Astra Zeneca. Additionally, he received lecture fees from Novo Nordisk, Astra Zeneca, Merck, and Abbott Nutrition. Furthermore, BH conducted clinical trials in collaboration with Novo Nordisk, Lilly, and Boehringer Ingelheim. John B. Dixon was a consultant at and sat on the advisory boards of Nestle Health Science and Reshape Lifesciences. He also sat on the advisory boards and also received speaker fees from Novo Nordisk and Lilly.